Representative Nita Lowey

Representing the 17th District of New York

Lowey Announces $502,883 in Federal Funding for New York Medical College

September 4, 2018
Press Release
National Institutes of Health grant will be used for study of obesity-driven cardiovascular diseases.

VALHALLA, NY – Congresswoman Nita Lowey (D-NY17/Rockland-Westchester), Ranking Member on the House Appropriations Committee, today announced that the National Institutes of Health’s (NIH) National Heart, Lung, and Blood Institute (NHLBI) has awarded a $502,883 federal grant to New York Medical College for heart and vascular diseases research.

“New York Medical College is a leading biomedical research institution, and these federal funds will help advance its groundbreaking research,” said Congresswoman Lowey. This funding will support research that improves our understanding of the link between obesity and cardiovascular disease, increasing the likelihood of improved health outcomes of those struggling with obesity. I will continue my work as Ranking Member on the House Appropriations Committee to secure greater funding for medical research institutions, so that they can help Americans live longer, healthier lives.”

The NIH grant will enable New York Medical College researchers to better understand and, ideally, prevent obesity-driven cardiovascular diseases.

“Obesity has earned the name ‘the silent disease’ because its adverse effects are insidious in the development of cardiovascular disease including hypertension, heart failure, and stroke as well as diabetes,” said Dr. Nader G. Abraham, Professor of Medicine and Pharmacology at New York Medical College. “The goal of this study is to understand how obesity contributes to increases in blood pressure, cardiovascular disease and insulin resistance with the aim of identifying genetic and molecular mechanisms that can control the detrimental outcomes of obesity.  Not all obese subjects are at high risk of developing cardiovascular diseases.  The most prominent factor that contributes to obesity driven cardiovascular diseases is the size and characteristics of the fat cells.  The larger the size of the fat cells the more chances to develop high blood pressure and cardiovascular diseases.  Our studies will examine the characteristics of the fat cells and will use conventional and target specific drugs to improve the function of the fat cells and consequently ameliorate and prevent the development of obesity driven hypertension and cardiovascular diseases.”

As the highest-ranking Democrat on the House Appropriations Committee, Congresswoman Lowey was instrumental in securing a $3 billion increase in federal funding for NIH as part of the Omnibus Appropriations Act of 2018. The $3 billion, or 8.8%, increase from the FY2017 enacted level is the largest increase in NIH funding in 15 years.

###